Erlanger Oncology and Hematology — Chattanooga, Tennessee

Erlanger Oncology and Hematology is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Erlanger Oncology and Hematology has participated in 2 clinical trials.

Therapeutic areas: Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma Transitional Cell.

Sponsors: Astellas Pharma Global Development, Inc., Seagen Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erlanger Oncology and Hematology?

Erlanger Oncology and Hematology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erlanger Oncology and Hematology conducted?

Erlanger Oncology and Hematology has 2 clinical trials on record. Their work covers Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma Transitional Cell.

Is Erlanger Oncology and Hematology accredited by Crixeo Health?

Erlanger Oncology and Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Erlanger Oncology and Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.